Loring Wolcott & Coolidge Fiduciary Advisors LLP Embecta Corp. Transaction History
Loring Wolcott & Coolidge Fiduciary Advisors LLP
- $11.1 Billion
- Q3 2024
A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Embecta Corp. stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 191 shares of EMBC stock, worth $3,978. This represents 0.0% of its overall portfolio holdings.
Number of Shares
191
Previous 193
1.04%
Holding current value
$3,978
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding EMBC
# of Institutions
405Shares Held
51.1MCall Options Held
162KPut Options Held
61K-
Black Rock Inc. New York, NY9.19MShares$192 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7MShares$146 Million0.0% of portfolio
-
River Road Asset Management, LLC3.48MShares$72.4 Million0.69% of portfolio
-
American Century Companies Inc Kansas City, MO3.02MShares$62.9 Million0.03% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.73MShares$56.9 Million0.72% of portfolio
About Embecta Corp.
- Ticker EMBC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 57,836,500
- Market Cap $1.2B
- Description
- Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...